Modern antiretroviral therapy (ART) has improved the lives of people living with HIV (PLHIV)
but currently requires daily adherence. We assessed prevalence and correlates of …

Background Optimal adherence to antiretroviral therapy (ART) is necessary for people living
with HIV/AIDS (PLHIV). There have been relatively few systematic analyses of factors that …

Background The daily oral dosing requirement for antiretroviral therapy (ART) may be
challenging for some people living with HIV (PLWHIV) with comorbid conditions …

Rationale Since 2001, antiretroviral therapy (ART) for people living with HIV (PLHIV) has
been available in the Lao People's Democratic Republic (PDR). A key factor in the …

For ideal clinical benefit, human immunodeficiency virus (HIV)-infected individuals should
receive continuous medication. This is the first nationwide antiretroviral therapy (ART) …

Successful HIV treatment is contingent on sustained high levels of treatment adherence.
Several barriers to optimal adherence have been documented. In this article, we first review …

Background: Among those accessing treatment, highly active antiretroviral therapy (HAART)
has transformed HIV into a chronic and manageable condition. However, high levels of …

Background Missing more than one tablet of contemporary antiretroviral therapy (ART) per
month increases the risk of virological failure. Recent studies evaluating a comprehensive …

Background Socially disadvantaged groups, such as drug users, sex workers and homeless
individuals, are labelled as “hard-to-reach”(HTR) in public health and medical research. HIV …

In light of the increasing availability of generic highly active antiretroviral therapy (HAART) in
India, further data are needed to examine variables associated with HAART nonadherence …